首页 | 本学科首页   官方微博 | 高级检索  
     

α-Gal抗原与动物源性医疗器械免疫原性风险控制
引用本文:柯林楠,;方玉,;单永强,;冯晓明,;徐丽明,;王春仁. α-Gal抗原与动物源性医疗器械免疫原性风险控制[J]. 中国临床康复, 2014, 0(25): 4051-4056
作者姓名:柯林楠,  方玉,  单永强,  冯晓明,  徐丽明,  王春仁
作者单位:[1]中国食品药品检定研究院,北京市100050; [2]温州医科大学,浙江省温州市352035
基金项目:再生型医用植入器械国家工程实验室PI项目“动物源性生物材料免疫原性检测与评价技术研究”(2012NELRMD002);中国食品药品检定研究院中青年研究发展基金“动物源性脱细胞生物材料中残留免疫原性因子检测方法研究”(2011C2)
摘    要:背景:目前动物源性医疗器械被广泛应用于临床,尽管它的有效性得到了认可,但它的安全性特别是免疫原性日益受到人们的关注。目的:为了保证动物源性医疗器械的质量安全,研究其免疫原性风险控制。方法:作者应用计算机检索 Sciencedirect 数据库、Wiley-Blackewel 电子期刊数据库和万方数据库中1985年1月至2013年6月的文章,在标题和中以“α-Gal抗原,免疫原性,异种移植”或“α-Gal antigen, immunity, xenotransplantation”为检索词进行检索。结果与结论:目前对异种植入物抗原中Galα1-3Gal抗原(即α-Gal抗原)的研究较多。α-Gal抗原存在于大量非灵长类哺乳动物、新世纪猴体内糖基化合物中,在人类及旧世纪猴体内不表达,但在人体中存在抗α-Gal抗体。α-Gal抗原与抗α-Gal抗体的结合形成了异种移植的免疫屏障。为了保证动物源性医疗器械的使用安全有效,应对动物源性材料进行选择,采用适当的工艺减少或去除α-Gal 抗原,同时还应建立灵敏度高、重复性好的α-Gal抗原检测方法。

关 键 词:生物材料  材料相容性  α-Gal抗原  免疫原性  异种移植

Alpha-Gal antigen and immunity risk control of animal-derived medical devices
Affiliation:Ke Lin-nan, Fang Yu, Shan Yong-qiang, Feng Xiao-ming, Xu Li-ming, Wang Chun-ren (1National Institutes for Food and Drug Control, Beijing 100050, China; 2Wenzhou Medical University, Wenzhou 352035, Zhejiang Province, China)
Abstract:BACKGROUND:Medical devices from animals are commonly used in clinical application. Despite their efficiency is widely accepted, their safety, especialy immunity has been concerned. OBJECTIVE:To investigate immunity risk control to medical devices from animals for safety consideration. METHODS:Using “α-Gal antigen, immunity, xenotransplantation” in Chinese and English as the key words, the first author conducted a computer search of Science direct database (www.sciencedirect.com), Wiley-Blackewel database (http://onlinelibrary.wiley.com) and Wanfang database (www.wanfang.com.cn) through screening the titles and abstracts. RESULTS AND CONCLUSION:Increasing evidence shows that, Gal α1-3Gal antigen (α-Gal antigen) is recognized as the major antigen and abundantly expressed on glycoconjugates of non-primate mammals and New World monkeys. In contrast, the α-gal epitope is not expressed on glycoconjugates of humans and Old World monkeys. Instead, they produce a very large amount of natural anti-α-Gal antibody that specificaly binds the α-galepitope. The binding of human natural anti-α-Gal to α-gal epitopes expressed on non-primate mammal animals was expected to be unique immunological barrier in xenotransplantation. Therefore, it is important to choose raw materials, reduce or eliminate the α-Ggal epitope, establish highα-Ggal epitope detection methods with high sensitivity and good repeatability for achieving a greater safety and efficiency of medical devices from animals.
Keywords:antigen  transplantation,heterologous  review
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号